World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
195
Citations
143902
World Ranking
351
National Ranking
233

Medicine

D-Index
196
Citations
152847
World Ranking
210
National Ranking
140

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Joseph Jankovic is affiliated with Baylor College of Medicine in the United States. Their research predominantly focuses on clinical psychology, neurology, and cognitive neuroscience within the broader fields of medicine, psychology, and neuroscience. The main topics explored in their work include obsessive-compulsive spectrum disorders, autism spectrum disorder research, botulinum toxin and related neurological disorders, attention deficit hyperactivity disorder, neurological disorders and treatments, body image and dysmorphia studies, and Parkinson's disease mechanisms and treatments.

The research output of Joseph Jankovic includes several notable recent papers: Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments (2020) published in Neurotherapeutics; Synaptic processes and immune-related pathways implicated in Tourette syndrome (2021) in Translational Psychiatry; Treatment of tics associated with Tourette syndrome (2020) in Journal of Neural Transmission; Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome (2021) in JAMA Network Open; and Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome (2021) also in JAMA Network Open.

Frequent publication venues for their work include JAMA Network Open, Movement Disorders Clinical Practice, Movement Disorders, Neurotherapeutics, and Translational Psychiatry.

Joseph Jankovic collaborates regularly with several co-authors, including Michael S. Okun, Daniëlle C. Cath, Donald L. Gilbert, Dongmei Yu, and Jae Hoon Sul. These collaborations reflect a network engaged in neurological and psychological research related to movement and neuropsychiatric disorders.

Best Publications

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • Parkinson’s disease: clinical features and diagnosis

    J Jankovic

  • Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) Report of the NINDS-SPSP International Workshop*

    I. Litvan;Y. Agid;D. Calne;G. Campbell

  • Phenomenology and classification of dystonia: a consensus update.

    Alberto Albanese;Kailash Bhatia;Susan B. Bressman;Mahlon R. DeLong

  • Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

    Mike A Nalls;Cornelis Blauwendraat;Costanza L Vallerga;Karl Heilbron

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy

    I. J. Schatz;R. Bannister;R. L. Freeman;C. G. Goetz

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

    Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe

  • Variable expression of Parkinson's disease A base‐line analysis of the DAT ATOP cohort

    Joseph Jankovic;Michael P McDermott;Jonathan T Carter;Susan A Gauthier

  • Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

    R. Holloway;I. Shoulson;K. Kieburtz;M. McDermott

  • THERAPEUTIC USES OF BOTULINUM TOXIN

    Joseph Jankovic;Mitchell F. Brin

  • A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

    C. Warren Olanow;Olivier Rascol;Robert Hauser;Paul D. Feigin

  • Parkinson's Disease and Movement Disorders

    Joseph Jankovic;Eduardo Tolosa

  • Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

    J.G. Nutt;K.J. Burchiel;C.L. Comella;J. Jankovic

  • How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

    Glenn T. Stebbins;Christopher G. Goetz;David J. Burn;Joseph Jankovic

  • Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    J.A. Obeso;M. Stamelou;M. Stamelou;C.G. Goetz;W. Poewe

  • Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

    D. M. Simpson;A. Blitzer;A. Brashear;C. Comella

  • Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.

    William J Marks;Raymond T Bartus;Joao Siffert;Charles S Davis

  • The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.

    Tianhong Pan;Seiji Kondo;Weidong Le;Joseph Jankovic

  • DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

    Zhen Hong;Min Shi;Kathryn A. Chung;Joseph F. Quinn

Frequent Co-Authors

Weidong Le
Weidong Le Chinese Academy of Sciences
William G. Ondo
William G. Ondo Cornell University
Christopher G. Goetz
Christopher G. Goetz Rush University Medical Center
Robert G. Grossman
Robert G. Grossman Houston Methodist
Harvey S. Singer
Harvey S. Singer Johns Hopkins University School of Medicine
Anthony E. Lang
Anthony E. Lang University of Toronto
Rajesh Pahwa
Rajesh Pahwa University of Kansas
Jonathan W. Mink
Jonathan W. Mink University of Rochester
Robert A. Hauser
Robert A. Hauser University of South Florida
Joshua M. Shulman
Joshua M. Shulman Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t always mean becoming a physician. There are several alternative yet impactful paths in the healthcare field, many of which can be started or continued online. Choosing an online degree can make education more accessible, flexible, and affordable—crucial benefits for busy adults or those changing careers.

Advanced clinical roles like nurse practitioners can benefit from cheap DNP online programs, which offer doctoral-level nursing education without the high price tag. If your interests lie in pharmacy, PharmD online programs can prepare you for a rewarding pharmacist career.

Not all healthcare roles involve direct patient care. For those interested in data, patient records, or healthcare systems management, healthcare informatics degree programs offer training in the latest technology and regulations shaping the industry. Additionally, individuals looking for quick-entry careers might consider affordable medical billing and coding programs to join the administrative side of healthcare.

Exploring these alternative degrees and certifications can lead to fulfilling and stable careers, all with the convenience of online learning.

Best Scientists Citing Joseph Jankovic

Trending Scientists